...
首页> 外文期刊>Surgery >Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: Influence on serum thyroglobulin level, recurrence rate, and postoperative complications
【24h】

Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: Influence on serum thyroglobulin level, recurrence rate, and postoperative complications

机译:临床淋巴结阴性的甲状腺乳头状甲状腺癌的预防性中央淋巴结清扫术:对血清甲状腺球蛋白水平,复发率和术后并发症的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In papillary thyroid microcarcinoma (PTMC), regional lymph node metastasis (LNM) is associated with a increased locoregional recurrence rate. Yet, prophylactic central lymph node dissection (CLND) targeting subclinical central LNM continues to be a matter of debate in the treatment of PTMC, which generally carries an excellent prognosis. The aim of our study was to investigate the benefits and risks of prophylactic CLND in patients with clinically node-negative PTMC. Methods: This study included 232 patients who underwent surgery for clinically node-negative PTMC from 1999 to 2006. Of these 232 patients, 113 underwent only total thyroidectomy (TT) and 119 underwent TT in conjunction with prophylactic bilateral CLND (TT with CLND). We then compared serum thyroglobulin (Tg) levels, recurrence rates, and postoperative complications between the 2 groups (TT only and TT with CLND). Results: The postoperative stimulated serum Tg level was significantly less in the TT with CLND group than in the TT only group (1.07 vs 2.24 ng/mL, respectively; P =.022). The stimulated Tg levels in the 2 groups became similar, however, after low-dose radioactive iodine treatment (0.44 ng/mL vs 0.69 ng/mL, respectively; P = 0.341). There was no significant difference in 3-year locoregional control rates after TT with CLND and TT only (98.3% vs 96.5%, respectively; P =.368). Although the frequency of permanent hypocalcemia was approximately 3 times greater in the TT with CLND group (5.6%) than in the TT only group (1.8%), this finding did not reach statistical significance. Conclusion: With prophylactic CLND, the postoperative Tg level can significantly decrease. However, prophylactic CLND is not helpful in decreasing short-term locoregional recurrence in patients with clinically node-negative PTMC. Finally, the risk of permanent hypocalcemia may increase after CLND.
机译:背景:在甲状腺乳头状微癌(PTMC)中,局部淋巴结转移(LNM)与局部复发率增加相关。然而,针对亚临床中心LNM的预防性中央淋巴结清扫术(CLND)在PTMC的治疗中仍是一个争论的问题,PTMC通常具有良好的预后。我们研究的目的是研究临床淋巴结阴性PTMC患者进行预防性CLND的益处和风险。方法:本研究包括1999年至2006年间232例因淋巴结阴性PTMC临床手术的患者。在这232例患者中,仅进行全甲状腺切除术(TT)的113例,以及预防性双侧CLND(TT合并CLND)的119例。然后,我们比较了两组(仅TT和含CLND的TT)之间的血清甲状腺球蛋白(Tg)水平,复发率和术后并发症。结果:CLND组TT的术后刺激血清Tg水平显着低于仅TT组(分别为1.07 vs 2.24 ng / mL; P = .022)。但是,在低剂量放射性碘治疗后,两组中刺激的Tg水平变得相似(分别为0.44 ng / mL和0.69 ng / mL; P = 0.341)。仅使用CLND和TT的TT后3年局部区域控制率无显着差异(分别为98.3%和96.5%; P = .368)。尽管CLND组(5.6%)的永久性低钙血症发生率比仅TT组(1.8%)高大约3倍,但这一发现没有统计学意义。结论:预防性CLND可使术后Tg水平明显降低。但是,预防性CLND并不能减少临床淋巴结阴性PTMC患者的短期局部复发。最后,CLND后永久性低钙血症的风险可能增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号